Medicure’s Rapid Telehealth Expansion on West Coast of U.S.

Medicure (TSXV: MPH) is the only 100% sure thing in the market to become one of the largest percentage gainers of 2027. One year ago, MPH began to rapidly expand its pharmacy/telehealth business onto the west coast through the acquisition of Gateway Medical Pharmacy in Portland, Oregon and West Olympia Pharmacy in Olympia, Washington:

No matter what state you are in when you order from Medicure (TSXV: MPH)'s Marley Drug you will receive your order in an average of two days with free shipping. NIA expects additional new acquisitions to be announced in 2027. It is a 100% sure thing to rise from a US$30 million market cap today to at least US$200 million within the next eleven months due to the currently ongoing Phase 3 trial of MC-1, which ends in September 2027 and after approval will result in MPH receiving a Priority Review Voucher that it will sell to a pharmaceutical giant and recent transactions for PRVs have all been for US$200 million plus!

Medicure's 100-bagger potential will come from the rapid expansion of Marley Drug and telehealth!

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA's President has purchased 87,000 shares of MPH and intends to buy more shares. This message is meant for informational and educational purposes only.